Results 201 to 210 of about 49,871 (286)

Women's critical experiences with the pap smear for the development of cervical cancer screening devices. [PDF]

Heliyon, 2023
Arrivillaga M, Bermúdez PC, García-Cifuentes JP, Rodríguez-López M, Neira D, Vargas-Cardona HD.   +5 more
europepmc   +1 more source

Economic Evaluation of Cervical Cancer Screening by HPV DNA, VIA, and Pap smear Methods in Indonesia. [PDF]

Asian Pac J Cancer Prev
Hafidz F, Icanervilia AV, Rizal MF, Listiani P, Setyaningsih H, Sasanti ML, Ekawati FM, Atthobari JA, Utami TW, Trirahmanto A, Tjokroprawiro BA, Harsono AB, Masytoh LS, Haryani W, Subekti Y, Nadjib M.   +15 more
europepmc   +1 more source

Routine Pap smear screening in Pakistan: A current perspective. [PDF]

Ann Med Surg (Lond), 2022
Bhimani S, Aashish, Khatri G, Hasan MM.
europepmc   +1 more source

Community-based Cultural Predictors of Pap Smear Screening in Nova Scotia

, 2004
Grace Johnston, Christopher J. Boyd, Margery A. MacIsaac   +2 more
openalex   +2 more sources

Risk factors of recurrent cervical intraepithelial neoplasm 2/3 after primary excisional conization/LEEP treatments: A follow-up nationwide cohort study

European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Objective: Follow-up human papillomavirus (HPV) testing 6 months after treatment is suggested for women with cervical intraepithelial neoplasm (CIN) 2/3. However, the Pap smear remains the only feasible tool in areas with limited resources.
Hung Shen, Mei-Hsuan Wu, Jian-Jhih Lin, Heng-Cheng Hsu, Yi-Jou Tai, Chia-Ying Wu, Chia-Yi Lee, Yen-Han Wang, Ying-Cheng Chiang   +8 more
doaj  

Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening. [PDF]

mBio
Atkins HM, Uslu AA, Li JJ, Shearer DA, Brendle SA, Han C, Kozak M, Lopez P, Nayar D, Balogh KK, Abendroth C, Copper J, Cheng KC, Christensen ND, Zhu Y, Avril S, Burgener AD, Murooka TT, Hu J.   +18 more
europepmc   +1 more source

Privacy Preserved Cervical Cancer Detection Using Convolutional Neural Networks Applied to Pap Smear Images. [PDF]

Comput Math Methods Med, 2023
Alsubai S, Alqahtani A, Sha M, Almadhor A, Abbas S, Mughal H, Gregus M.   +6 more
europepmc   +1 more source

HPV DNA status and clinical history of patients are supplements for accurate reporting of the cytological Pap smear. [PDF]

Sci Rep
Ali M, Sinha R, Kumar A, Karim S, Irfan M, Kumar S, Sinha S, Kumar A, Ghosh A, Singh M.   +9 more
europepmc   +1 more source

Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program. [PDF]

Asian Pac J Cancer Prev, 2023
Thipsanthiah K, Kamsa-Ard S, Musika W, Teemuangsai W, Hawlader MDH.   +4 more
europepmc   +1 more source

Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population‐based study [PDF]

, 2008
Angel Chao, Kuang‐Hung Hsu, Chyong‐Huey Lai, Huei‐Jean Huang, Swei Hsueh, Sheue‐Rong Lin, Shih‐Ming Jung, Fang‐Yu Chao, Shang‐Lang Huang, Chu‐Chun Huang, Jung‐Erh Yang, Ting‐Chang Chang   +11 more
openalex   +1 more source